Improvement in renal cholesterol emboli syndrome after simvastatin

Lancet. 1998 May 2;351(9112):1331-2. doi: 10.1016/S0140-6736(05)79058-9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anticholesteremic Agents / therapeutic use*
  • Embolism, Cholesterol / drug therapy*
  • Humans
  • Male
  • Renal Artery Obstruction / drug therapy
  • Renal Artery Obstruction / etiology*
  • Simvastatin / therapeutic use*

Substances

  • Anticholesteremic Agents
  • Simvastatin